Promising Results for Vutrisiran in Cardiac Amyloidosis ...Middle East

News by : (Medscape) -
The HELIOS-B study has shown a significant reduction in the primary endpoint of all-cause mortality and recurrent cardiovascular events with vutrisiran. Medscape Medical News

Hence then, the article about promising results for vutrisiran in cardiac amyloidosis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Promising Results for Vutrisiran in Cardiac Amyloidosis )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار